| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 201 | ARRAY OF COMPLEMENTARY INFANT/YOUNG CHILD NUTRITIONAL COMPOSITIONS | US14659846 | 2015-03-17 | US20150181916A1 | 2015-07-02 | Petra Klassen; Corinne Magliola |
| The present invention relates to infant/young child nutrition. A set of nutritional compositions having beneficial effects to infants/young children is disclosed. The set of nutritional compositions comprises at least two compositions with varying amounts of components which impart a beneficial effect to the infants young/children. A nutrition kit for infants/young children comprising the set of nutritional compositions is also disclosed as well as a method for manufacturing the set of nutritional components. A dosage regimen is also disclosed. | ||||||
| 202 | SYNBIOTIC MIXTURE | US14639734 | 2015-03-05 | US20150174179A1 | 2015-06-25 | Nobert Sprenger; Francois Morgan; Rafael Berrocal; Marcel Braun; Christine Cherbut; Peter Duncan |
| This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group consisting of GalNAcα1-3Gal β1-4Glc, Gal β1-6GalNacα1-3Gal β1-4Glc and combinations thereof, 20-95 wt % of at least one neutral oligosaccharide selected from the group consisting of Galβ1-6Gal, Galβ1-6Galβ1-4Glc, Galβ1-6Galβ1-6Glc, Galβ1-3Galβ1-3Glc, Galβ1-3Galβ1-4Glc, Galβ1-6Galβ1-6Galβ1-4Glc, Galβ1-6Galβ1-3Galβ1-4Glc, Galβ1-3Galβ1-6Galβ1-4Glc, Galβ1-3Galβ1-3Galβ1-4Glc and combinations thereof and 2-50 wt % of at least one sialylated oligosaccharide selected from the group consisting of NeuAcα2-3Galβ1-4Glc, NeuAcα2-6Galβ1-4Glc and combinations thereof. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections. | ||||||
| 203 | Culture medium for Lactobacillus acidophilus and Streptococcus faecalis, composition comprising the same and preparation method thereof | US12527104 | 2008-02-03 | US09040037B2 | 2015-05-26 | Binhua Chen; Xuesong Wang; Liang Zhang |
| The present invention provides a triple vital bacteria composition, including: powder of Bifidobacterium longum, powder of Lactobacillus acidophilus, and powder of Streptococcus faecalis. The present invention further provides a method for preparing the above triple vital bacteria composition, as well as the protection agents, the fermenting culture medium and the seed culture medium used therein. | ||||||
| 204 | METHOD OF DOUBLE-COATING LACTIC ACID BACTERIA | US14505425 | 2014-10-02 | US20150111247A1 | 2015-04-23 | Myung-Jun Chung; Young-Chai Cho; Soo-Dong Kim; Un-Pyoe Hong |
| The present disclosure relates to production of double-coated lactic acid bacteria using peptides and polysaccharide. Double-coated lactic acid bacteria show improved heat-resistance, acid-resistance, bile-resistance, storage stability and excellent survival rate when reaching intestine. | ||||||
| 205 | Infant cereal comprising non-replicating probiotic microorganisms | US13319651 | 2010-05-11 | US08916374B2 | 2014-12-23 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of infant cereals. In particular, the present invention relates to the field of infant cereals that can be used to strengthen the immune system of the infant and/or that can be used to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to an infant cereal comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms. | ||||||
| 206 | Frozen confections containing probiotic micro-organisms | US13884547 | 2011-11-11 | US08877179B2 | 2014-11-04 | Annick Mercenier; Guenolee Prioult; Sophie Nutten |
| The present invention relates to the field of frozen yoghurt. In particular, the present invention provides frozen yoghurt compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may bioactive heat treated probiotic micro-organisms, for example. The present inventions also relates to health benefits provided by these non-replicating probiotic micro-organisms. | ||||||
| 207 | Capsules containing vital cells or tissues | US11210424 | 2005-08-24 | US08859853B2 | 2014-10-14 | Masanori Asada; Yumi Hatano; Ryosei Kamaguchi; Hideki Sunohara |
| Artificial seeds formed of a seamless soft capsule are provided herein. The artificial seed contains a meristematic plant cell or tissue. The artificial seed has a structure of three or more layers containing an innermost layer, an inner layer covering the innermost layer, and an outer layer covering the inner layer. The innermost layer can contain an aqueous liquid, the inner layer can be formed by an inner membrane containing hardened oil, and the outer layer can be formed of a biodegradable outer membrane. | ||||||
| 208 | NOVEL COMPOSITIONS | US14129851 | 2012-06-30 | US20140255366A1 | 2014-09-11 | Birgitte Yde |
| The invention relates to a dry compositions for lactic acid bacteria and in particular to a dry composition comprising from 109 to 1013 cfu/g of the composition of lactic acid bacteria cells, wherein the composition is characterized by that it also comprises following amounts of protective agents (all amounts of protective agents below are given relative to 1 g of lactic acid bacteria cells in the composition): from 6 to 9 g of trehalose, from 0.1 to 1 g of inulin and from 0.5 to 3 g of hydrolyzed casein, and by that it does not comprise a salt of alginic acid. The composition has an improved storage stability of the cell of interest. Comparison experiments have been made between compositions with and without alginate and it has been found that there is substantially no difference between compositions with or without alginate with regard to stability. Further, the invention relates to a method for preparing a dry lactic acid bacteria composition. | ||||||
| 209 | SPOONABLE YOGURT PREPARATIONS CONTAINING NON-REPLICATING PROBIOTIC MICRO-ORGANISMS | US13884539 | 2011-11-10 | US20130287874A1 | 2013-10-31 | Annick Mercenier; Guenolee Prioult; Sophie Nutten |
| The present invention relates to the field of spoonable yogurt compositions. In particular, the present invention provides spoonable yogurt compositions comprising non-replicating probiotic micro-organisms. These non-replicating probiotic micro-organisms may be bioactive heat treated probiotic micro-organisms, for example. The present invention also relates to health benefits provided by these non-replicating probiotic micro-organisms. | ||||||
| 210 | Probiotic Strains for Use in Improving Transepithelial Resistance | US13700482 | 2011-05-30 | US20130216510A1 | 2013-08-22 | Sophie Legrain-Raspaud; Gianfranco Grompone; Sandrine Capronnier; Isabelle Chambaud; Biliana Lesic |
| The invention relates to the use of lactic acid bacteria, for use in improving transepithelial resistance and more particularly in treating and/or preventing constipation and/or irritable bowel disease. | ||||||
| 211 | METHOD FOR PRODUCING A FERMENTED FOOD CONTAINING BIFIDOBACTERIA | US13579270 | 2011-08-31 | US20130189396A1 | 2013-07-25 | Toshitaka Odamaki; Sumiko Yonezawa; Hiroshi Maruyama; Noritoshi Takahashi |
| A milk raw material is fermented by using Lactococcus lactis not having cell wall-enveloped proteinase and a Bifidobacterium bacterium. The Lactococcus lactis is, for example, a Lactococcus lactis having a property that, when this bacterium and the Bifidobacterium bacterium are inoculated into a medium containing 1% (W/W) of glucose and 10% (W/W) of reduced skim milk powder in amounts of 5.0×106 to 2.0×108 CFU and 1.0×107 to 3.0×109 CFU per 1 ml of the medium, respectively, and cultured, and the medium is rapidly cooled to 10° C. from culture temperature when pH of the medium becomes 4.6 to 5.5, and stored at 10° C. for 2 weeks, survival rate of the Bafidobacterium bacterium is maintained to be 30% or more. | ||||||
| 212 | BIFIDOBACTERIUM STRAIN | US13468512 | 2012-05-10 | US20130004540A1 | 2013-01-03 | Liam O'mahony; Barry Kiely |
| Bifidobacterium strain AH121A is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent. | ||||||
| 213 | BIFIDOBACTERIUM LONGUM AND FUNCTIONAL GI DISORDERS | US13391343 | 2010-08-24 | US20120230956A1 | 2012-09-13 | Peter McLean; Gabriela Bergonzelli de Gonda; Stephen Michael Collins; Premysl Bercik; Elena Verdu de Bercik |
| The present invention generally relates to the field of probiotic bacteria. In particular it relates to Bifidobacterium longum, such as Bifidobacterium longum ATCC BAA-999, and its use in ingestible compositions. The composition described in the present invention may be used to treat or prevent functional GI disorders. | ||||||
| 214 | DRY WHOLE MILK PREPARATIONS CONTAINING PROBIOTIC MICRO-ORGANISMS | US13319964 | 2010-05-11 | US20120121561A1 | 2012-05-17 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for young children. In particular, the present invention relates to dry whole milk preparations comprising probiotic micro-organisms to be administered to young children older than 12 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | ||||||
| 215 | T CELL APOPTOSIS INDUCER | US13167483 | 2011-06-23 | US20110250189A1 | 2011-10-13 | Shigeru Fujiwara; Hiroki Kanzato; Satoshi Hachimura |
| An inducer of T cell apoptosis and a health food for inducing T cell apoptosis comprising as an active ingredient of a lactic acid bacterium belonging to the genus Lactobacillus or the genus Bifidobacterium are disclosed. Particularly preferred lactic acid bacteria belonging to the genus Lactobacillus or the genus Bifidobacterium are Lactobacillus acidophilus L-92 (FERM BP-4981), Lactobacillus amylovorus CP1750 (FERM BP-10532), Bifidobacterium catenulatum CP2829 (FERM BP-10533) and Bifidobacterium longum CP760 (FERM BP-10531). The inducer of T cell apoptosis of the invention is useful in the prevention and cure of a disease such as an organ-specific autoimmune disease or type I allergy. | ||||||
| 216 | CULTURE MEDIUM FOR LACTOBACILLUS ACIDOPHILUS AND STREPTOCOCCUS FAECALIS, COMPOSITION COMPRISING THE SAME AND PREPARATION METHOD THEREOF | US12527104 | 2008-02-03 | US20100119487A1 | 2010-05-13 | Binhua Chen; Xuesong Wang; Liang Zhang |
| The present invention provides a triple vital bacteria composition, including: powder of Bifidobacterium longum, powder of Lactobacillus acidophilus, and powder of Streptococcus faecalis. The present invention further provides a method for preparing the above triple vital bacteria composition, as well as the protection agents, the fermenting culture medium and the seed culture medium used therein. | ||||||
| 217 | Probiotic infant products | US12284208 | 2008-09-19 | US20100074870A1 | 2010-03-25 | William Michael Russell; Michael Ceddia |
| The present invention is directed to an infant formula or children's nutritional product comprising a protein source, a fat source, a carbohydrate source, and B. longum AH1206. | ||||||
| 218 | METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION | US12091050 | 2006-10-06 | US20090221486A1 | 2009-09-03 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising uronic acid oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 219 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION | US12091011 | 2006-10-06 | US20090220639A1 | 2009-09-03 | Joachim Schmitt; Bernd Stahl; Jan Knol |
| The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | ||||||
| 220 | Method for Stimulating the Intestinal Flora | US12083612 | 2006-10-20 | US20090162323A1 | 2009-06-25 | Günther Boehm; Bernd Stahl; Jan Knol |
| The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c) at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. | ||||||
QQ群二维码
意见反馈
意见反馈